State Street Corp Sells 188,035 Shares of C4 Therapeutics

Dec 25, 2024 · State Street Corp lowered its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC - Free Report) by 6.3% during the third quarter, according to its most recent …

3%
OFF

State Street Corp Sells 188,035 Shares Of C4 Therapeutics

2 weeks from now

Dec 25, 2024 · State Street Corp lowered its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC - Free Report) by 6.3% during the third quarter, according to its most recent …

marketbeat.com

3%
OFF

State Street Corp Cuts Position In C4 Therapeutics, Inc.

2 weeks from now

Dec 25, 2024 · State Street Corp lowered its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 6.3% during the third quarter, according to its most recent …

defenseworld.net

3%
OFF

State Street Corp Sells 50,883 Shares Of Arcturus Therapeutics …

2 weeks from now

Dec 21, 2024 · State Street Corp trimmed its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Free Report) by 3.3% during the third quarter, according to its most recent …

marketbeat.com

7%
OFF

State Street Corp Buys 10,401 Shares Of Autolus Therapeutics Plc ...

2 weeks from now

Jan 2, 2025 · State Street Corp increased its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 1.7% in the third quarter, according to the company in its …

defenseworld.net

0%
OFF

State Street Corp Buys 21,201 Shares Of Outlook Therapeutics, Inc ...

2 weeks from now

Jan 3, 2025 · State Street Corp boosted its stake in Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent 13F …

defenseworld.net

4%
OFF

State Street Corp Sells 331,746 Shares Of Vera Therapeutics, Inc ...

2 weeks from now

Dec 17, 2024 · State Street Corp decreased its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 15.4% in the 3rd quarter, according to its most recent 13F …

marketbeat.com

6%
OFF

State Street Corp Sells 38,010 Shares Of Apartment Investment And ...

2 weeks from now

Dec 19, 2024 · State Street Corp lessened its position in Apartment Investment and Management (NYSE:AIV – Free Report) by 0.6% during the 3rd quarter, according to its most recent filing …

americanbankingnews.com

5%
OFF

State Street Corp Sells 173,932 Shares Of Celldex Therapeutics, Inc ...

2 weeks from now

Dec 17, 2024 · State Street Corp trimmed its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 6.5% in the third quarter, according to the company in its …

marketbeat.com

$340000
OFF

204 Woodcliff Ave APT C4, North Bergen, NJ 07047 | Zillow

2 weeks from now

Nov 3, 2023 · 204 Woodcliff Ave Apt C4, North Bergen NJ, is a Condo home that contains 800 sq ft.It contains 2 bedrooms and 1 bathroom.This home last sold for $340,000 in November 2023. …

zillow.com

$81000
OFF

8701 Bergenline Ave Unit C4, North Bergen, NJ 07047 | Redfin

2 weeks from now

1 bed, 914 sq. ft. condo located at 8701 Bergenline Ave Unit C4, North Bergen, NJ 07047 sold for $81,000 on Nov 10, 1994. View sales history, tax history, home value estimates, and overhead …

redfin.com

FAQs about State Street Corp Sells 188,035 Shares of C4 Therapeutics Coupon?

How much is State Street Corp's TSCAN Therapeutics stock worth?

State Street Corp’s holdings in TScan Therapeutics were worth $3,767,000 as of its most recent filing with the Securities and Exchange Commission. Other large investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP acquired a new position in TScan Therapeutics in the 2nd quarter valued at $70,000. ...

How many shares does State Street Corp own in SAGE Therapeutics?

The fund owned 2,926,239 shares of the biopharmaceutical company’s stock after purchasing an additional 451,377 shares during the quarter. State Street Corp’s holdings in Sage Therapeutics were worth $21,127,000 at the end of the most recent reporting period. ...

Did SG Americas buy TSCAN Therapeutics?

SG Americas Securities LLC bought a new position in shares of TScan Therapeutics in the third quarter worth $78,000. The Manufacturers Life Insurance Company acquired a new position in TScan Therapeutics in the second quarter valued at about $90,000. ...

Who owns TSCAN Therapeutics (TCRX)?

Finally, Cornercap Investment Counsel Inc. acquired a new stake in TScan Therapeutics during the second quarter worth about $134,000. Institutional investors and hedge funds own 82.83% of the company’s stock. TCRX opened at $3.00 on Tuesday. ...

Does MetLife Investment Management LLC own TSCAN Therapeutics?

MetLife Investment Management LLC lifted its position in TScan Therapeutics by 129.1% during the third quarter. MetLife Investment Management LLC now owns 23,363 shares of the company’s stock worth $116,000 after purchasing an additional 13,164 shares during the period. ...